Biomedical NER for the Enterprise with Distillated BERN2 and the Kazu Framework

1 code implementation • 1 Dec 2022 • Wonjin Yoon, Richard Jackson, Elliot Ford, Vladimir Poroshin, Jaewoo Kang

In order to assist the drug discovery/development process, pharmaceutical companies often apply biomedical NER and linking techniques over internal and public corpora.

Drug Discovery NER